News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
Market overviews
Direct comparison of products for laboratory and process: Use the comprehensive market overviews to compare products according to your requirements and obtain further information from suppliers.
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
17-Feb-2009 - Cyplasin Biomedical Ltd., announced that it has completed the granting of a worldwide exclusive license to Bioxen Ltd for its Cyplasin technology for therapeutic use. Under terms of the license Bioxen will further develop the Cyplasin protein for use in skin cancer, melanoma and other potential ...
03-Jun-2008 - Cyplasin Biomedical Ltd announced that its Australian Patent application Nr 2002361168 has been granted on April 29th, 2008 and the notice of acceptance has been published in the Supplement to the Australian Official Journal of Patents. The claims cover the production methods for Cyplasin in ...
27-May-2008 - Cyplasin Biomedical Ltd announced that its Japanese Patent application Nr Hei 9-516992 has been granted. The claims cover the characterization of a cytotoxic protein from the mucus of the sea hare Aplysia punctata and its use to treat cancer. "It is gratifying to receive the approval of our ...
06-Nov-2007 - Cyplasin Biomedical Ltd today announced that its U.S. Patent application Nr 10/501,098 entitled "Cytotoxic Cyplasin of the Sea Hare, Aplysia punctata, cDNA Cloning and Expression of Bioreactive Recombinants" has been granted as US patent Number US 7,271,242 B2. The patent claims cover the ...
09-Oct-2007 - In recent third party validated cell based laboratory tests, Cyplasin-SC(TM) has shown a unique toxicity to many tumor cells, including human melanoma cells. However normal human cells are not affected by Cyplasin-SC(TM) at concentrations used to kill the tumor cells. These positive validated ...
07-Sep-2007 - It is well known that many cancer types - or even the same cancer in different patients - show different sensitivities to a given therapeutic treatment. In earlier studies Cyplasin-SC(TM) has shown to be an efficient killer of many cancer cell types whereas normal human cells were left intact. An ...
© 1997-2024 LUMITOS AG, All rights reserved
